Srdjan Djurovic's research group:
Psychiatric molecular genetics
The goal of The Psychiatric Molecular Genetics Group is to develop a strong research environment in molecular genetics of psychiatric disorders, and to provide a platform with molecular genetic services to research groups in psychiatric disorders.
About the group
The group is part of the TOP study (http://www.med.uio.no/klinmed/forskning/grupper/top/) which is a major collaborative effort studying clinical characteristics, neurocognitive functioning and brain biology of psychotic disorders.
The group’s current research aims are:
- to perform molecular genetic analysis in order to increase the knowledge and expertise in psychiatric genetics and identify the molecular networks underlying psychiatric disease.
- to continually develop an organization to support psychiatric genetic studies with design and planning, help with biobanking procedures and high-throughput genotyping efforts.
We particularly focus on schizophrenia, bipolar disorder, and related neuropsychiatric phenotypes and among others apply genome wide association studies (GWAS) as well as sequencing, a front line technology at Oslo University Hospital. Through the use of extensive bioinformatics and biostatistics work in collaboration with key national and international collaborators, we identify and confirm new gene variants. Finally, we focus on how to translate the genetic discoveries to specific phenotypes in clinical samples, as part of ongoing analytical studies.
From left: Lavinia Athanasiu, Elin Inderhaug, Srdjan Djurovic, Ida Elken Sønderby, Lars J. Hansson, Luiz Goulart.
Early phase drug development: From idea to concept
Feb 3, 2017
Feb 2, 2017
Oncolytic peptide LTX-315; the road from basic science to clinical trials
Jan 26, 2017